» Articles » PMID: 36232548

The Microbiota-Gut-Brain Axis in Psychiatric Disorders

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2022 Oct 14
PMID 36232548
Authors
Affiliations
Soon will be listed here.
Abstract

Modulating the gut microbiome and its influence on human health is the subject of intense research. The gut microbiota could be associated not only with gastroenterological diseases but also with psychiatric disorders. The importance of factors such as stress, mode of delivery, the role of probiotics, circadian clock system, diet, and occupational and environmental exposure in the relationship between the gut microbiota and brain function through bidirectional communication, described as "the microbiome-gut-brain axis", is especially underlined. In this review, we discuss the link between the intestinal microbiome and the brain and host response involving different pathways between the intestinal microbiota and the nervous system (e.g., neurotransmitters, endocrine system, immunological mechanisms, or bacterial metabolites). We review the microbiota alterations and their results in the development of psychiatric disorders, including major depressive disorder (MDD), schizophrenia (SCZ), bipolar disorder (BD), autism spectrum disorder (ASD), and attention-deficit hyperactivity disorder (ADHD).

Citing Articles

Gut over Mind: Exploring the Powerful Gut-Brain Axis.

Petrut S, Bragaru A, Munteanu A, Moldovan A, Moldovan C, Rusu E Nutrients. 2025; 17(5).

PMID: 40077713 PMC: 11901622. DOI: 10.3390/nu17050842.


Investigating Causal Links Between Gut Microbiota and Neurological Disorders via Genome-Wide Association Studies.

Jiang Q, Wu L, Wang X, Gao Z, Liu X, Zhang W Mol Neurobiol. 2025; .

PMID: 40075040 DOI: 10.1007/s12035-025-04770-3.


Global research trends in the intestinal microflora and depression: bibliometrics and visual analysis.

Xu Q, Xiang Q, Tan Z, Yang Q Front Cell Infect Microbiol. 2025; 15:1507667.

PMID: 40070374 PMC: 11893873. DOI: 10.3389/fcimb.2025.1507667.


Neurological sequelae of long COVID: a comprehensive review of diagnostic imaging, underlying mechanisms, and potential therapeutics.

Talkington G, Kolluru P, Gressett T, Ismael S, Meenakshi U, Acquarone M Front Neurol. 2025; 15:1465787.

PMID: 40046430 PMC: 11881597. DOI: 10.3389/fneur.2024.1465787.


Utilizing metagenomic profiling and machine learning model to identify bacterial biomarkers for major depressive disorder.

Wang X, Cao D, Zhang H, Chen W, Sun J, Hu H Front Psychiatry. 2025; 16:1539596.

PMID: 40041700 PMC: 11876151. DOI: 10.3389/fpsyt.2025.1539596.


References
1.
De Angelis M, Francavilla R, Piccolo M, De Giacomo A, Gobbetti M . Autism spectrum disorders and intestinal microbiota. Gut Microbes. 2015; 6(3):207-13. PMC: 4616908. DOI: 10.1080/19490976.2015.1035855. View

2.
Bull-Larsen S, Mohajeri M . The Potential Influence of the Bacterial Microbiome on the Development and Progression of ADHD. Nutrients. 2019; 11(11). PMC: 6893446. DOI: 10.3390/nu11112805. View

3.
Li M, Van Esch B, Wagenaar G, Garssen J, Folkerts G, Henricks P . Pro- and anti-inflammatory effects of short chain fatty acids on immune and endothelial cells. Eur J Pharmacol. 2018; 831:52-59. DOI: 10.1016/j.ejphar.2018.05.003. View

4.
Bures J, Cyrany J, Kohoutova D, Forstl M, Rejchrt S, Kvetina J . Small intestinal bacterial overgrowth syndrome. World J Gastroenterol. 2010; 16(24):2978-90. PMC: 2890937. DOI: 10.3748/wjg.v16.i24.2978. View

5.
Kaczmarek J, Thompson S, Holscher H . Complex interactions of circadian rhythms, eating behaviors, and the gastrointestinal microbiota and their potential impact on health. Nutr Rev. 2017; 75(9):673-682. PMC: 5914376. DOI: 10.1093/nutrit/nux036. View